New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export PBM’s income statement to Excel — free account
Psyence Biomedical Ltd.
PBM
2.97
0.11
+3.85%
After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.
Follow PBM
Alert me
Psyence Biomedical Ltd. (PBM) Return on invested capital
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2026 | −41.2% | 374.33 |
| FY2025 | −415.6% | (415.57) |
| FY2024 | 0.00% | 0.00 |
| FY2023 | 0.00% | — |
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| BIVI BioVie Inc. compare | 0.00% |
| HIND Vyome Holdings, Inc. compare | 0.00% |
| AEON AEON Biopharma, Inc. compare | 0.00% |
| LSTA Lisata Therapeutics, Inc. compare | 0.00% |
| BCDA BioCardia, Inc. compare | 0.00% |
| PASG Passage Bio, Inc. compare | 0.00% |
| JSPR Jasper Therapeutics, Inc. compare | 0.00% |
| RADX Radiopharm Theranostics Limited - Sponsored ADR compare | — |
| PBM Psyence Biomedical Ltd. | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.06% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)